Building Multidimensional Biomarker Views of Type 2 Diabetes on the Basis of Protein Microheterogeneity

BACKGROUND: In 2008, the US Food and Drug Administration (FDA) issued a Guidance for Industry statement formally recognizing (during drug development) the conjoined nature of type 2 diabetes (T2D) and cardiovascular disease (CVD), which has precipitated an urgent need for panels of markers (and mean...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Borges, Chad R., Oran, Paul E., Buddi, Sai, Jarvis, Jason W., Schaab, Matthew R., Rehder, Douglas S., Rogers, Stephen P., Taylor, Thomas, Nelson, Randall W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3761388/
https://ncbi.nlm.nih.gov/pubmed/21402800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/clinchem.2010.156976
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados